CPT code 20245 denotes an open bone biopsy, a surgical diagnostic procedure used to obtain bone tissue samples from lesions for pathological or infectious disease evaluation. This code is clinically important because bone biopsy results directly influence diagnosis, staging, and treatment decisions for malignancy, infection, and metabolic bone disorders. Nationally, accurate coding for open bone biopsy affects clinical documentation, utilization metrics, and claims adjudication across major payers.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for the procedure, typical sites of service, and the payer landscape. The publication also outlines commonly used billing modifiers associated with procedural coding and highlights benchmarking elements and policy considerations relevant to reimbursement and claims processing.

The report is designed to inform billing managers, surgical teams, and policy analysts about coding expectations, the role of the procedure in care pathways, and areas where payer policies commonly affect coverage and documentation. Data not available in the input will be identified explicitly in specific sections of the full publication.